A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.	Aortic Arch Syndromes, Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Takayasu arteritis, ankylosing spondylitis, ankylosis, aortic disorder, arteritis, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, immune system disorder, juvenile idiopathic arthritis, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, polymyalgia rheumatica, psoriasis, psoriatic arthritis, rheumatic disorder, skin disorder, skin vascular disease, spondylitis, temporal arteritis, vascular disorder, vasculitis, vertebral column disorder	Not yet recruiting	Not stated	2025-01-09		NCT06766552

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Second Affiliated Hospital of Zhejiang University	Hangzhou	China	4